Last reviewed · How we verify
NCT04542395
COVID-2019 Testing and Vaccination Among African American and Latinx Public Housing Residents
NA trial testing Increasing Willingness and Uptake of COVID-19 Testing and Vaccination in Coronavirus. Withdrawn.
30 November 2025
Quick facts
| Lead sponsor | Charles Drew University of Medicine and Science |
|---|---|
| Phase | NA |
| Status | Withdrawn |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Start date | 1 June 2023 |
| Primary completion | 30 November 2025 |
| Estimated completion | 30 November 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Increasing Willingness and Uptake of COVID-19 Testing and Vaccination
Conditions studied
- Coronavirus — all drugs for Coronavirus →
Sponsor
Charles Drew University of Medicine and Science
Who can join
18 and older, any sex, with Coronavirus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This proposal seeks to enhance acceptability and uptake of COVID-19 testing and vaccination to engage African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to reduce barriers and implement innovate strategies to engage this population in the uptake of COVID-19 testing and vaccination.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Interventions to increase COVID-19 vaccine uptake: a scoping review.
Andreas M, Iannizzi C, Bohndorf E, Monsef I, et al · · 2022 · cited 24× · PMID 35920693 · DOI 10.1002/14651858.cd015270
Verify or expand the search:
- PubMed search for NCT04542395
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Coronavirus
Currently open trials in the same condition.
- NCT04772170 — Observational Digital Biomarker Discovery in Respiratory Virus Challenge Studies · recruiting
- NCT05868239 — Impact of Aerosol Box Use During Cardiopulmonary Arrest: A Multicenter Study · NA · recruiting
- NCT04359836 — A Study to Explore the Role of Gut Flora in COVID-19 Infection · recruiting
- NCT04376034 — Convalescent Plasma Collection and Treatment in Pediatrics and Adults · Phase 3 · recruiting
- NCT04568148 — COVID-19 Biorepository · active not recruiting
Other Charles Drew University of Medicine and Science trials
Trials by the same sponsor.
- NCT06075732 — ACTIVATE in Public Housing · NA · completed
- NCT05605028 — A Mental Health Intervention for a Community Program Called the PowerObesity · NA · withdrawn
- NCT05805306 — Entre Herman@s: Promoting Health Among Latino MSM · NA · completed
- NCT05471141 — Preventing and Managing Cognitive Impairment · NA · withdrawn
- NCT04761692 — Increasing COVID-19, Influenza, and Pneumonia Vaccine Uptake · NA · withdrawn
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04542395 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Charles Drew University of Medicine and Science
- Last refreshed: 19 August 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04542395.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing